Clinical Trials
3 trialsNCT07136181 2025-11-28
NBM-BMX-UM
Novelwise Pharmaceutical Corporation
Phase 1/2 Recruiting
NCT05415072 2025-07-20
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
Novartis
Phase 1/2 Active not recruiting
NCT03052127 2024-02-01
Study in Subjects With Small Primary Choroidal Melanoma
Aura Biosciences
Phase 1/2 Completed